HST Bulletin
There are currently 336 guests online.
African Malaria Network Trust
AMANET Launches Large-Scale Testing of Candidate Malaria Vaccine MSP3-LSP in Mali, Dar es salaam
The African Malaria Network Trust (AMANET) and researchers at the Malaria Research Training Center (MRTC), University of Bamako in Mali have launched a large scale study to evaluate the candidate malaria vaccine merozoite surface protein-3 long synthetic peptide (MSP3-LSP).
Global strategy aims for effective malaria vaccine by 2025
4 DECEMBER 2006 BANGKOK -- A report by the world's leading international health organizations today calls for joint action to accelerate the development and licensing of a highly effective malaria vaccine.
Travel-related risks pose unique malaria threat in South Africa
Malaria remains one of the leading causes of infection, morbidity and mortality in Africa. It is estimated between 300 and 500 million new cases are reported worldwide every year, and malaria causes one million childhood deaths annually.
Malaria Red Reference - Southern Africa
Malaria Red Reference is a project by the World Health Organization (WHO) that aims to improve health workers' access to malaria information in the Southern Africa region.
- Visitor: 219,628
© Health Systems Trust 2011. All Rights Reserved.
This site complies with the HONcode standard for trustworthy health information. Confidentiality of data relating to individuals and visitors, including their identity, is respected by this website. Our website does not host any form of advertisement. HST undertakes to honour or exceed the legal requirements of information privacy that applies in South Africa. Access to Information - Section 51 of the Access to Information Act